Advertisements



We are Sorry, This Page doesn't Exist


Novartis Announces Positive Data on Sickle Cell Disease Drug

Novartis (NVS) announced positive data from a phase II study, SUSTAIN, on pipeline candidate crizanlizumab which deferred the time to first s.....»»

Category: worldSource: nytDec 12th, 2017

Novartis Announces Positive Data on Urticaria Drug Xolair

Novartis AG (NVS) announced new positive data on chronic spontaneous urticaria (CSU) drug Xolair from a phase IIIb study, OPTIMA. .....»»

Category: smallbizSource: nytSep 18th, 2017

Novartis Announces Positive Data on Cardiovascular Drug

Novartis AG (NVS) announced positive primary data on pipeline candidate canakinumab (ACZ885). Novartis AG NVS a.....»»

Category: personnelSource: nytAug 28th, 2017

Alexion announces positive data in trial of rare blood disorder drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 15th, 2018

Roche (RHHBY) Announces Positive Data on Leukemia Drug

Zacks.....»»

Category: topSource: redinewsSep 19th, 2017

Roche (RHHBY) Announces Positive Data on Leukemia Drug

Roche Holdings AG (RHHBY) announced positive results from the phase III study, MURANO on leukemia drug Venclexta. Roche Holdings AG RHHBY announced positive results from the phase III study, MURANO.The study evaluated Vencle.....»»

Category: personnelSource: nytSep 19th, 2017

Novartis Announces Long-Term Data on Psoriasis Drug Cosentyx

Novartis' (NVS) Cosentyx showed robust skin clearance data over a period of five years in patients with moderate-to-severe plaque psoriasis. Novartis AG NVS announced long-last.....»»

Category: smallbizSource: nytSep 14th, 2017

AzurRx BioPharma announces "positive" preclincal data for AZX1103

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 18th, 2018

Crispr Therapeutics announces "positive" data presentation of CAR-T program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Novartis announces JAMA Cardiology publication of Entresto data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 4th, 2018

How a failed Pfizer rare heart-disease drug came back to flatten its rivals

The drug was shot down by the FDA in a related disease several years ago, so recent positive results came as a surprise......»»

Category: topSource: marketwatchApr 2nd, 2018

Sellas announces "positive" interim data from Phase 2b NeuVax trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 2nd, 2018

Altimmune announces "positive" data from Phase 2a study of NasoVax

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 27th, 2018

Reata announces "positive" top-line data from bardoxolone methyl trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 22nd, 2018

DIGITAL HEALTH BRIEFING: Top announcements from HIMSS 2018 — Novartis looks into virtual drug trials — Value-based care could hurt small hospitals

Welcome to Digital Health Briefing, a newsletter providing the latest news, data, and insight on how digital technology is d.....»»

Category: topSource: businessinsiderMar 12th, 2018

Novartis CEO: We Need a Different Approach to Drug Discovery

We need a shift from broad-based development strategies. Heart disease remains the number one cause of death worldwide, accoun.....»»

Category: europeSource: fortuneMar 12th, 2018

Abbott announces new long-term data for HeartMate 3 heart pump

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 11th, 2018

Esperion hopes heart drug data will support FDA approval in 2018, Forbes says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 7th, 2018

Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes

Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes.....»»

Category: earningsSource: benzingaMar 6th, 2018

G1 Therapeutics announces "positive" Trilaciclib Phase 2a data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 5th, 2018